비교리스트

 카트 문의
시장보고서
상품코드
1536182

세계의 Anorexiants 시장

Anorexiants
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 273 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Anorexiants 세계 시장은 2030년까지 11억 달러에 달할 것으로 예상됩니다

2023년 8억 7,320만 달러로 추정되는 Anorexiants 세계 시장은 2023-2030년의 분석 기간 동안 연평균 3.1% 성장하여 2030년에는 11억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 경구 투여는 CAGR 3.5%를 기록하여 분석 기간 종료 시점에 7억 20만 달러에 도달할 것으로 예상됩니다. 피하 투여 부문은 분석 기간 동안 CAGR 2.6%의 성장률을 나타낼 것으로 추정됩니다.

미국 시장 2억 3,790만 달러로 추정, 중국은 CAGR 6.1%로 성장할 것으로 예상

미국의 Anorexiants 시장은 2023년 2억 3,790만 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023년부터 2030년까지 6.1%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년에는 2억 2,250만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 1.0%와 2.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.6%의 성장률을 보일 것으로 예상됩니다.

세계 Anorexiants 시장 - 주요 동향 및 촉진요인 요약

식욕억제제라고도 알려진 식욕억제제는 식욕을 감소시키고 체중감량을 돕기 위해 고안된 의약품 화합물로 주로 비만 치료에 사용됩니다. 이 약물은 중추신경계에 작용하여 포만감과 포만감을 유발하여 환자의 칼로리 섭취를 줄이는 데 도움을 줍니다. 일반적으로 처방되는 안렉시안트에는 펜테르민, 디에틸프로피온, 로카세린과 같은 새로운 안렉시안트가 있으며, 이들은 기분과 식욕을 조절하는 뇌 물질의 방출을 자극하여 작용합니다. 이러한 약물의 효과는 신체 활동 증가와 식습관 개선과 같은 생활습관 변화와 함께 사용하면 더욱 효과적입니다. 이러한 약물은 당뇨병, 심장병, 고혈압 등 많은 만성 질환과 관련된 비만 관리에 큰 이점을 제공하지만, 심박수 증가, 혈압 상승, 의존성 문제 등 잠재적인 부작용과 위험도 수반합니다. 따라서 의료진의 신중한 환자 선별 및 모니터링이 필요합니다.

지난 몇 년동안, 무배당제 시장은 의약품 개발 및 규제 당국의 승인 과정에서 상당한 진전을 이루었습니다. 배고픔과 포만감에 관여하는 생화학적 경로에 대한 이해도가 높아짐에 따라, 제약회사들은 부작용 가능성이 적은 새로운 경로를 표적으로 하는 약물 개발에 집중하고 있습니다. 예를 들어, 식욕 조절에 관여하는 여러 경로를 표적으로 하는 병용요법은 부작용을 최소화하면서 체중감량 효과를 높일 수 있을 것으로 기대되고 있습니다. 또한, 비만 치료에서 개인 맞춤형 의료가 강조되고 있으며, 유전자 및 바이오마커 프로파일링을 통해 환자 개개인의 필요에 맞게 약물 요법을 조정함으로써 치료 효과를 높이고 치료 관련 합병증을 줄일 수 있습니다. 이 분야는 또한 전 세계 비만 유병률 증가와 효과적인 체중 관리 솔루션에 대한 시장의 큰 수요에 힘입어 연구개발에 대한 투자가 증가하고 있는 추세에 힘입어 성장하고 있습니다.

아놀렉시언트 시장의 성장은 전 세계 비만율 증가, 비만과 관련된 건강 위험에 대한 임상적 이해 증가, 예방적 건강 관리에 대한 관심 증가 등 여러 요인에 의해 주도되고 있습니다. 식습관의 변화와 운동량 감소로 인해 전 세계적으로 비만율이 증가함에 따라 효과적인 치료 솔루션에 대한 수요는 지속적으로 증가하고 있습니다. 또한, 의료진과 환자들은 당뇨병 및 심혈관 질환과 같은 관련 건강 문제를 예방하기 위해 체중 관리의 중요성을 인식하고 있습니다. 의약품 연구 개발의 기술적 진보도 시장 확대에 중요한 역할을 하고 있으며, 식욕 조절의 특정 분자 경로를 표적으로 삼도록 설계된 새로운 약물이 시장에 진입하고 있습니다. 소비자 행동은 부작용이 적고 효과가 더 오래 지속되는 약물을 선호하는 방향으로 변화하고 있으며, 이는 차세대 식욕억제제 개발에 영향을 미치고 있습니다. 또한, 혁신적인 비만 치료제의 조기 승인을 위한 규제 당국의 지원은 이러한 치료제의 빠른 발전과 가용성을 촉진하고 있습니다. 이러한 요인들이 종합적으로 작용하여 비만 치료제 시장의 성장을 견인하고 있으며, 이는 효과적이고 안전하며 접근하기 쉬운 비만 치료제의 필요성에 대한 인식이 널리 퍼져 있음을 반영합니다.

조사 대상 기업 예시(총 86건)

  • Arena Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • CHEPLAPHARM Arzneimittel GmbH
  • Cigna Healthcare
  • Currax Pharmaceuticals LLC(CONTRAVE)
  • Elite Pharmaceuticals Inc.
  • Epic Pharma LLC
  • Hi-Tech Pharmaceuticals
  • KVK Tech Inc.
  • Lannett Co.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Productos Medix SA de CV
  • VIVUS LLC;

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 러시아
    • 기타 유럽
    • 아시아태평양
    • 호주
    • 인도
    • 한국
    • 기타 아시아태평양
    • 라틴아메리카
    • 아르헨티나
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
    • 중동
    • 이란
    • 이스라엘
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동
    • 아프리카

    제4장 경쟁

    LSH 24.09.05

    Global Anorexiants Market to Reach US$1.1 Billion by 2030

    The global market for Anorexiants estimated at US$873.2 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$700.2 Million by the end of the analysis period. Growth in the Subcutaneous Administration segment is estimated at 2.6% CAGR over the analysis period.

    The U.S. Market is Estimated at US$237.9 Million While China is Forecast to Grow at 6.1% CAGR

    The Anorexiants market in the U.S. is estimated at US$237.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$222.5 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

    Global Anorexiants Market - Key Trends and Drivers Summarized

    Anorexiants, also known as appetite suppressants, are pharmaceutical compounds designed to decrease appetite and aid in weight loss, primarily used in the treatment of obesity. These drugs affect the central nervous system to create a feeling of satiety or fullness, helping patients to consume fewer calories. Commonly prescribed anorexiants include phentermine, diethylpropion, and newer entries like lorcaserin, which work by stimulating the release of brain chemicals that control mood and appetite. The effectiveness of these medications is often enhanced when combined with lifestyle changes, such as increased physical activity and dietary modifications. While these medications offer significant benefits in managing obesity, which is linked to numerous chronic diseases like diabetes, heart disease, and hypertension, they also come with potential side effects and risks such as increased heart rate, elevated blood pressure, and potential dependency issues. This necessitates careful patient screening and monitoring by healthcare providers.

    Over the past few years, the anorexiants market has seen considerable advancements in drug development and regulatory approval processes. With a growing understanding of the biochemical pathways involved in hunger and satiety, pharmaceutical companies have been focusing on developing drugs that target new pathways with potentially fewer side effects. For instance, combination therapies that target multiple pathways involved in appetite regulation are showing promise in enhancing weight loss outcomes while minimizing adverse effects. Additionally, there is a growing emphasis on personalized medicine in obesity treatment, where genetic and biomarker profiling is used to tailor drug therapies to individual patient needs, thereby improving efficacy and reducing treatment-related complications. The field has also benefited from increased investment in research and development, driven by the rising prevalence of obesity worldwide and the substantial market demand for effective weight management solutions.

    The growth in the anorexiants market is driven by several factors, including an escalating global obesity epidemic, greater clinical understanding of the health risks associated with obesity, and an increasing emphasis on preventive healthcare. As obesity rates climb globally, driven by changes in diet and decreases in physical activity, the demand for effective treatment solutions continues to rise. Furthermore, healthcare providers and patients are becoming more aware of the importance of managing weight to prevent associated health issues such as diabetes and cardiovascular diseases. Technological advancements in drug research and development are also playing a crucial role in the market expansion, with new drugs designed to target specific molecular pathways of appetite control entering the market. Consumer behavior is shifting towards favoring medications with fewer side effects and more sustained effects, influencing the development of next-generation anorexiants. In addition, regulatory support for fast-tracking the approval of innovative obesity treatments is fostering rapid advancements and availability of these medications. Collectively, these factors are propelling the growth of the anorexiants market, reflecting a broad recognition of the need for effective, safe, and accessible obesity treatments.

    Select Competitors (Total 86 Featured) -

    • Arena Pharmaceuticals Inc.
    • Bausch Health Companies Inc.
    • CHEPLAPHARM Arzneimittel GmbH
    • Cigna Healthcare
    • Currax Pharmaceuticals LLC (CONTRAVE)
    • Elite Pharmaceuticals Inc.
    • Epic Pharma LLC
    • Hi-Tech Pharmaceuticals
    • KVK Tech Inc.
    • Lannett Co. Inc.
    • Novartis AG
    • Novo Nordisk AS
    • Pfizer Inc.
    • Productos Medix SA de CV
    • VIVUS LLC;

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Global Economic Update
      • Anorexiants - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Rising Global Prevalence of Obesity Throws the Spotlight on Anorexiants
      • Growing Acceptance of Pharmacotherapy in Weight Management Expands Addressable Market
      • Consumer Demand for Non-Surgical Weight Loss Solutions Drives Adoption of Anorexiants
      • Increasing Spending Weight Management Products Bodes Well for Market Growth
      • Rising Incidence of Diabetes and Cardiovascular Diseases Linked to Obesity Spurs Demand for Anorexiants
      • Emergence of Generic Drugs Challenges Growth but Expands Accessibility in Anorexiants Market
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Anorexiants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 3: World Historic Review for Anorexiants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 4: World 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
      • TABLE 5: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 6: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 7: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Subcutaneous Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 9: World Historic Review for Subcutaneous Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 10: World 16-Year Perspective for Subcutaneous Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 11: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 12: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 13: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 15: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 16: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 20: USA Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 21: USA Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 22: USA 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 23: USA Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 24: USA Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 25: USA 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 26: Canada Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 27: Canada Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 28: Canada 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 29: Canada Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 30: Canada Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 31: Canada 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • JAPAN
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 32: Japan Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 33: Japan Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 34: Japan 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 35: Japan Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 36: Japan Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 37: Japan 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • CHINA
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 38: China Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 39: China Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 40: China 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 41: China Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 42: China Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 43: China 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • EUROPE
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 44: Europe Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 45: Europe Historic Review for Anorexiants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 46: Europe 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 47: Europe Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Europe Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 49: Europe 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 50: Europe Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Europe Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 52: Europe 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • FRANCE
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 53: France Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 54: France Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 55: France 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 56: France Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 57: France Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 58: France 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • GERMANY
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 59: Germany Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 60: Germany Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 61: Germany 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 62: Germany Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 63: Germany Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 64: Germany 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 65: Italy Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 66: Italy Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 67: Italy 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 68: Italy Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 69: Italy Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 70: Italy 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 71: UK Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 72: UK Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 73: UK 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 74: UK Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 75: UK Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 76: UK 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • SPAIN
      • TABLE 77: Spain Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 78: Spain Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 79: Spain 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 80: Spain Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 81: Spain Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 82: Spain 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • RUSSIA
      • TABLE 83: Russia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 84: Russia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 85: Russia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 86: Russia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 87: Russia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 88: Russia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 90: Rest of Europe Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 91: Rest of Europe 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 93: Rest of Europe Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 94: Rest of Europe 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 96: Asia-Pacific Historic Review for Anorexiants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 97: Asia-Pacific 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
      • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 99: Asia-Pacific Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 100: Asia-Pacific 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 102: Asia-Pacific Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 103: Asia-Pacific 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • AUSTRALIA
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
      • TABLE 104: Australia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 105: Australia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 106: Australia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 107: Australia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 108: Australia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 109: Australia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • INDIA
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
      • TABLE 110: India Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 111: India Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 112: India 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 113: India Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 114: India Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 115: India 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • SOUTH KOREA
      • TABLE 116: South Korea Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 117: South Korea Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 118: South Korea 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 119: South Korea Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 120: South Korea Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 121: South Korea 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • REST OF ASIA-PACIFIC
      • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 123: Rest of Asia-Pacific Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 126: Rest of Asia-Pacific Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • LATIN AMERICA
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
      • TABLE 128: Latin America Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 129: Latin America Historic Review for Anorexiants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 130: Latin America 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
      • TABLE 131: Latin America Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 132: Latin America Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 133: Latin America 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 134: Latin America Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 135: Latin America Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 136: Latin America 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • ARGENTINA
      • TABLE 137: Argentina Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 138: Argentina Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 139: Argentina 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 140: Argentina Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 141: Argentina Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 142: Argentina 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • BRAZIL
      • TABLE 143: Brazil Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 144: Brazil Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 145: Brazil 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 146: Brazil Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 147: Brazil Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 148: Brazil 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • MEXICO
      • TABLE 149: Mexico Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 150: Mexico Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 151: Mexico 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 152: Mexico Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 153: Mexico Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 154: Mexico 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • REST OF LATIN AMERICA
      • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 156: Rest of Latin America Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 157: Rest of Latin America 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 159: Rest of Latin America Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 160: Rest of Latin America 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • MIDDLE EAST
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
      • TABLE 161: Middle East Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 162: Middle East Historic Review for Anorexiants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 163: Middle East 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
      • TABLE 164: Middle East Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 165: Middle East Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 166: Middle East 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 167: Middle East Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 168: Middle East Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 169: Middle East 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • IRAN
      • TABLE 170: Iran Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 171: Iran Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 172: Iran 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 173: Iran Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 174: Iran Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 175: Iran 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • ISRAEL
      • TABLE 176: Israel Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 177: Israel Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 178: Israel 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 179: Israel Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 180: Israel Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 181: Israel 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • SAUDI ARABIA
      • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 183: Saudi Arabia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 184: Saudi Arabia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 186: Saudi Arabia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 187: Saudi Arabia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • UNITED ARAB EMIRATES
      • TABLE 188: UAE Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 189: UAE Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 190: UAE 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 191: UAE Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 192: UAE Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 193: UAE 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • REST OF MIDDLE EAST
      • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 195: Rest of Middle East Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 196: Rest of Middle East 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 198: Rest of Middle East Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 199: Rest of Middle East 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • AFRICA
      • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
      • TABLE 200: Africa Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 201: Africa Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 202: Africa 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
      • TABLE 203: Africa Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 204: Africa Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 205: Africa 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 비교리스트
    0 건의 상품을 선택 중
    상품 비교하기
    전체삭제